| Literature DB >> 35087157 |
Chi Kyung Kim1,2, Chul-Ho Sohn3,4,5, Ki-Woong Nam6,7, Byung-Woo Yoon7,8, Inpyeong Hwang9.
Abstract
In acute ischemic stroke (AIS), the hemodynamics around the lesion are important because they determine the recurrence or prognosis of the disease. This study evaluated the effects of perfusion deficits in multiphase arterial spin labeling (ASL) and related radiological parameters on the occurrence of early recurrent ischemic lesions (ERILs) in AIS. We assessed AIS patients who underwent multiphase ASL within 24 h of symptom onset and follow-up diffusion-weighted imaging within 7 days. ASL perfusion deficit, arterial transit artifact (ATA), and intra-arterial high-intensity signal (IAS) were manually rated as ASL parameters. A total of 134 patients were evaluated. In the multivariable analyses, ASL perfusion deficit [adjusted odds ratio (aOR) = 2.82, 95% confidence interval = 1.27-6.27] was positively associated with ERIL. Furthermore, when ATA was accompanied, the ASL perfusion deficit was not associated with ERIL occurrence. Meanwhile, IAS showed a synergistic effect with ASL perfusion deficit on the occurrence of ERIL. In conclusion, we demonstrated the association between perfusion deficits in multiphase ASL with ERIL in patients with AIS. This close association was attenuated by ATA and was enhanced by IAS. ASL parameters may help identify high-risk patients of ERIL occurrence during the acute period.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35087157 PMCID: PMC8795409 DOI: 10.1038/s41598-022-05465-8
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics of patients with and without ERILs.
| No ERIL (n = 75) | ERIL (n = 59) | ||
|---|---|---|---|
| Age, years [IQR] | 71 [61–79] | 74 [65–80] | 0.218 |
| Sex, male, n (%) | 47 (62.7) | 37 (62.7) | 0.996 |
| Follow-up MRI time, days [IQR] | 2 [1–4] | 3 [2–4] | 0.520 |
| Hypertension, n (%) | 52 (69.3) | 44 (74.6) | 0.504 |
| Diabetes, n (%) | 29 (38.7) | 24 (40.7) | 0.813 |
| Hyperlipidemia, n (%) | 33 (44.0) | 31 (52.5) | 0.326 |
| Atrial fibrillation, n (%) | 23 (30.7) | 19 (32.2) | 0.849 |
| Ischemic heart disease, n (%) | 16 (21.3) | 14 (23.7) | 0.741 |
| Smoking, n (%) | 14 (18.7) | 8 (13.6) | 0.428 |
| History of stroke, n (%) | 19 (25.3) | 14 (23.7) | 0.831 |
| 0.843 | |||
| Intracranial-LAA | 18 (24.0) | 13 (22.0) | 0.789 |
| Extracranial-LAA | 11 (14.7) | 12 (20.3) | 0.387 |
| Cardioembolism | 27 (36.0) | 21 (35.6) | 0.961 |
| Cryptogenic | 19 (25.3) | 13 (22.0) | 0.657 |
| Initial NIHSS score [IQR] | 4 [2–8] | 3 [1–7] | 0.091 |
| IV thrombolysis, n (%) | 11 (14.7) | 5 (8.5) | 0.272 |
| HbA1c, % [IQR] | 5.9 [5.5–6.5] | 5.9 [5.7–6.9] | 0.407 |
| Fasting blood sugar, mg/dL [IQR] | 98 [87–116] | 98 [85–113] | 0.857 |
| Total cholesterol, mg/dL [IQR] | 161 [142–182] | 162 [137–202] | 0.898 |
| LDL cholesterol, mg/dL [SD] | 97 ± 36 | 100 ± 37 | 0.659 |
| HDL cholesterol, mg/dL [SD] | 48 ± 14 | 46 ± 14 | 0.439 |
| Triglyceride, mg/dL [IQR] | 92 [67–124] | 98 [76–153] | 0.389 |
| White blood cell, × 103/μL [IQR] | 7.15 [5.69–8.94] | 6.97 [5.68–9.95] | 0.761 |
| High-sensitivity CRP, mg/dL [IQR] | 0.11 [0.06–0.40] | 0.11 [0.05–0.26] | 0.655 |
| ASL perfusion deficit, n (%) | 43 (57.3) | 44 (74.6) | 0.038 |
| ATA, n (%) | 24 (32.0) | 13 (22.0) | 0.200 |
| IAS, n (%) | 7 (9.3) | 20 (33.9) | < 0.001 |
| Recanalization, n (%) | 12 (16.0) | 16 (27.1) | 0.116 |
ERIL early recurrent ischemic lesion, MRI magnetic resonance imaging, LAA large artery atherosclerosis, NIHSS National Institutes of Health Stroke Scale, IV intravenous, HbA1c hemoglobin A1c, LDL low-density lipoprotein, HDL high-density lipoprotein, CRP c-reactive protein, ASL arterial spin labeling, ATA arterial transit artifact, IAS intraarterial high-intensity signal.
Multivariable logistic regression analysis of possible predictors for early recurrent ischemic lesion.
| Crude OR (95% CI) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|
| Age, years | 1.02 [1.00–1.05] | 0.107 | 1.03 [1.00–1.06] | 0.042 |
| Sex, male | 1.00 [0.50–2.03] | 0.996 | 1.11 [0.53–2.32] | 0.792 |
| Initial NIHSS score | 0.97 [0.92–1.03] | 0.348 | 0.94 [0.88–1.01] | 0.086 |
| ASL perfusion deficit | 2.18 [1.04–4.59] | 0.040 | 2.82 [1.27–6.27] | 0.011 |
NIHSS National Institutes of Health Stroke Scale, ASL arterial spin labeling.
Multivariable logistic regression analyses of possible predictors for ERIL, considering the interactive effects between ASL perfusion deficit and ATA/IAS.
| Crude OR (95% CI) | Adjusted OR (95% CI) | |||
|---|---|---|---|---|
| Age, years | 1.02 [1.00–1.05] | 0.107 | 1.03 [1.00–1.07] | 0.039 |
| Sex, male | 1.00 [0.50–2.03] | 0.996 | 1.07 [0.50–2.27] | 0.869 |
| Initial NIHSS score | 0.97 [0.92–1.03] | 0.348 | 0.95 [0.89–1.01] | 0.108 |
| 0.006 | 0.003 | |||
| ASL deficit (−) ATA (−) | Ref | Ref | Ref | Ref |
| ASL deficit ( +) ATA (−) | 3.48 [1.51–8.05] | 0.004 | 4.48 [1.83–10.98] | 0.001 |
| ASL deficit ( +) ATA ( +) | 1.16 [0.46–2.88] | 0.756 | 1.47 [0.56–3.86] | 0.436 |
| Age, years | 1.02 [1.00–1.05] | 0.107 | 1.03 [1.00–1.07] | 0.043 |
| Sex, male | 1.00 [0.50–2.03] | 0.996 | 1.13 [0.52–2.42] | 0.759 |
| Initial NIHSS score | 0.97 [0.92–1.03] | 0.348 | 0.94 [0.88–1.01] | 0.105 |
| 0.001 | ||||
| ASL deficit (−) IAS (−) | Ref | Ref | Ref | Ref |
| ASL deficit ( +) IAS (−) | 1.42 [0.64–3.17] | 0.389 | 1.84 [0.78–4.31] | 0.164 |
| ASL deficit ( +) IAS ( +) | 6.10 [2.12–17.54] | 0.001 | 7.97 [2.59–24.51] | < 0.001 |
ERIL early recurrent ischemic lesion, ASL arterial spin labeling, ATA arterial transit artifact, IAS intraarterial high-intensity signal, NIHSS National Institutes of Health Stroke Scale.
Figure 1Effects of ATA and IAS on ERIL occurrence and locations. ATA arterial transit artifact, IAS intraarterial high-intensity signal, ERIL early recurrent ischemic lesion. (A) When accompanied by ATA, the incidence of ERIL-local was significantly lower in patients with ASL perfusion deficits (P = 0.030). However, in the case of ERIL-distant, the influence of ATA was unclear (P = 0.573). (B) Conversely, IAS significantly increased the incidence of ERIL-local in patients with ASL perfusion deficits (P = 0.022). Likewise, the impact of IAS on the occurrence of ERIL-distant was also less pronounced (P = 0.297).
Comparisons of baseline characteristics, ASL parameters, and ERIL according to stroke mechanisms.
| IC-LAA (n = 31) | EC-LAA (n = 23) | CE (n = 48) | Cryptogenic (n = 32) | ||
|---|---|---|---|---|---|
| ERIL | 13 (41.9) | 12 (52.2) | 21 (43.8) | 13 (40.6) | 0.843 |
| ERIL-local | 10 (32.3) | 9 (39.1) | 6 (12.5) | 5 (15.6) | 0.029 |
| ERIL-distant | 3 (9.7) | 3 (13.0) | 15 (31.3) | 8 (25.0) | 0.092 |
| ASL perfusion deficit | 23 (74.2) | 16 (69.6) | 30 (62.5) | 18 (56.2) | 0.463 |
| ATA | 10 (32.3) | 4 (17.4) | 15 (31.2) | 8 (25.0) | 0.580 |
| IAS | 9 (29.0) | 6 (26.1) | 8 (16.7) | 4 (12.5) | 0.314 |
| Recanalization | 5 (16.1) | 0 (0) | 16 (33.3) | 7 (21.9) | 0.012 |
| Age, years | 76 [60–81] | 75 [70–84] | 76 [66–81] | 70 [61–76] | 0.025 |
| Sex, male | 16 (51.6) | 17 (73.9) | 31 (64.6) | 20 (62.5) | 0.401 |
| Hypertension | 21 (67.7) | 21 (91.3) | 32 (66.7) | 22 (68.8) | 0.149 |
| Diabetes | 15 (48.4) | 9 (39.1) | 17 (35.4) | 12 (37.5) | 0.702 |
| Hyperlipidemia | 15 (48.4) | 16 (69.6) | 17 (35.4) | 16 (50.0) | 0.061 |
| Smoking | 6 (19.4) | 2 (8.7) | 5 (10.4) | 9 (28.1) | 0.130 |
| History of stroke | 8 (25.8) | 8 (34.8) | 11 (22.9) | 6 (18.8) | 0.578 |
| Initial NIHSS score | 3 [2–6] | 3 [1–4] | 5 [2–11] | 4 [1–6] | 0.126 |
| IV thrombolysis | 2 (6.5) | 1 (4.3) | 8 (16.7) | 5 (15.6) | 0.310 |
ASL arterial spin labeling, ERIL early recurrent ischemic lesion, IC-LAA intracranial large artery atherosclerosis, EC-LAA extracranial large artery atherosclerosis, CE cardioembolism, ATA arterial transit artifact, IAS intraarterial high-intensity signal, NIHSS National Institutes of Health Stroke Scale, IV intravenous.
Figure 2Representative cases of arterial spin labeling (ASL) perfusion deficit, arterial transit artifact (ATA), and intraarterial high-intensity signal (IAS) on multiphase ASL images. (A) ASL perfusion deficit, (B) arterial transit artifact, (C) intraarterial high-intensity signal.